Please wait a minute...

ISSN 1006-298X CN 32-1425/R

Home
About Journal
Editorial Board
Contribution
Journal
- Accepted
- Current Issue
- Archive
- Most Download
- Most Read
- Most Cited
- E-mail Alert
- RSS
Subscription
Advertising
Contact Us
中文

Journal

Current Issue Accepted Archive Adv Search Most Read Most Download Most Cited E-mail Alert RSS

WeChat

Current Issue

2022, 31 (3)

Previous Issue Next Issue

Bay11-7082 alleviated renal injury in membranous nephropathy by inhibiting podocyte pyroptosis LYU Daoyuan, JIANG Song, WANG Hui, ZHANG Mingchao, ZHU Xiaodong, YANG Fan, LI Shen, LIU Feng, ZENG Caihong, QIN Weisong, LI Limin, LIU Zhihong 2022, 31 (3): 201-209. DOI: 10.3969/j.issn.1006-298X.2022.03.001 Abstract( 672 ) PDF (5433KB) ( 358 )

Risk factors and prognosis of acute kidney injury in patients with lupus podocytopathy ZHANG Lulu, XIA Wen, XU Feng, CHEN Duqun, JIN Ying, LIU Zhengzhao, ZENG Caihong, HU Weixin 2022, 31 (3): 210-216. DOI: 10.3969/j.issn.1006-298X.2022.03.002 Abstract( 461 ) PDF (963KB) ( 340 )

Volume index change of blood formed elements with body volume and prognosis in critically ill patients DAI Xinlin, HU Zhen, GU Xiaoyan, ZHANG Haiqing, GE Yongchun, GONG Dehua 2022, 31 (3): 217-222. DOI: 10.3969/j.issn.1006-298X.2022.03.003 Abstract( 311 ) PDF (1089KB) ( 247 )

Establishment and application of a high-throughput screening model for Toll-like receptor 7 inhibitors ZHAO Yue, ZHENG Zuguo, ZHOU Ping, LI Ping, LIU Zhihong 2022, 31 (3): 223-230. DOI: 10.3969/j.issn.1006-298X.2022.03.004 Abstract( 487 ) PDF (3938KB) ( 355 )

Uremic patients with secondary hyperparathyroidism after parathyroidectomy： a prospective cohort study CHENG Ming, HUANG Bihong, TAO Ye, FAN Chunyan, WANG Mengjing, WANG Hongying, ZHANG Minmin 2022, 31 (3): 231-237. DOI: 10.3969/j.issn.1006-298X.2022.03.005 Abstract( 396 ) PDF (1217KB) ( 261 )

Clinicopathological characteristics and prognosis of antiglomerular basement membrane nephritis with antineutrophil cytoplasmic antibody ZHU Mengyue, WANG Jingjing, LE Weibo, JIN Ying, JIAO Chenfeng, ZHANG Haitao 2022, 31 (3): 238-243. DOI: 10.3969/j.issn.1006-298X.2022.03.006 Abstract( 423 ) PDF (907KB) ( 343 )

Influencing factors of restless legs syndrome in maintenance hemodialysis patients ZHANG Lanyue, TIAN Xiuxun, LEI Yan, WANG Xiaohua, LIU Yang, WU Jianhua, LI Jinhong, XUE Zhiqiang, XIE Minyan, HU Mingliang, DUAN Wenjuan, ZHENG Zhihua 2022, 31 (3): 244-249. DOI: 10.3969/j.issn.1006-298X.2022.03.007 Abstract( 379 ) PDF (835KB) ( 371 )

Advantage and application of incremenal peritoneal dialysis YU Yusheng 2022, 31 (3): 250-251. DOI: 10.3969/j.issn.1006-298X.2022.03.008 Abstract( 194 ) PDF (843KB) ( 301 )

Clinical application of incremental peritoneal dialysis YANG Xiao 2022, 31 (3): 252-253. DOI: 10.3969/j.issn.1006-298X.2022.03.009 Abstract( 176 ) PDF (714KB) ( 319 )

Clinical application of incremental peritoneal dialysis#br# #br# LYU Jing 2022, 31 (3): 254-255. Abstract( 126 ) PDF (851KB) ( 340 )

Application of spatial transcriptomics in kidney diseases#br# QIU Dandan, JIANG Song 2022, 31 (3): 256-260. DOI: 10.3969/j.issn.1006-298X.2022.03.011 Abstract( 581 ) PDF (1159KB) ( 1100 )

G2／M cell cycle arrest and renal interstitial fibrosis#br# LIU Minna, LIU Tianlong, XI Chunsheng 2022, 31 (3): 261-265. DOI: 10.3969/j.issn.1006-298X.2022.03.012 Abstract( 879 ) PDF (1514KB) ( 721 )

Hydroxychloroquine treatment in IgA nephropathy#br# WEI Kaiyue, MI Yan, WANG Caili 2022, 31 (3): 266-271. DOI: 10.3969/j.issn.1006-298X.2022.03.013 Abstract( 1641 ) PDF (1166KB) ( 668 )

Update on targeted treatment of IgA nephropathy#br# WANG Chang, WANG Ruizhi, WU Gang 2022, 31 (3): 271-276. DOI: 10.3969/j.issn.1006-298X.2022.03.014 Abstract( 919 ) PDF (1480KB) ( 923 )

Intravenous iron in patients undergoing maintenance hemodialysis:rethinking of the conclusion #br# of PIVOTAL study#br# XING Jie, ZHANG Xiaoliang 2022, 31 (3): 277-280. DOI: 10.3969/j.issn.1006-298X.2022.03.015 Abstract( 551 ) PDF (697KB) ( 293 )

Progress in diagnosis, treatment and prevention of catheter exit site infection in peritoneal dialysis#br# CHENG Shuiqin, YU Yusheng 2022, 31 (3): 281-285. DOI: 10.3969/j.issn.1006-298X.2022.03.016 Abstract( 529 ) PDF (989KB) ( 1062 )

α-Klotho in renal allograft function protection#br# ZHANG Aihua, ZHU yichen, LIU Wenhu 2022, 31 (3): 286-289. DOI: 10.3969/j.issn.1006-298X.2022.03.017 Abstract( 389 ) PDF (926KB) ( 383 )

Scrub typhus complicated with multiple organ dysfunction syndrome#br# LI Zhe, WANG Yang, XU Shutian, LI Shijun 2022, 31 (3): 290-295. DOI: 10.3969/j.issn.1006-298X.2022.03.018 Abstract( 386 ) PDF (1229KB) ( 858 )

Key points and recommendations in management of chronic kidney disease for primary health-care providers Expert panel on chronic kidney disease management recommendations for primary health-care providers 2022, 31 (3): 296-300. DOI: 10.3969/j.issn.1006-298X.2022.03.019 Abstract( 632 ) PDF (947KB) ( 301 )